One of the biggest threats facing CBD companies? Survival. CBD is already projected to hit over $16 billion in sales by 2024, so it's not surprising that there are over 3,000 brands in the market, hoping to ride the wave of success and reap the rewards.  

The designation of the cannabis business as essential caught some states and some state officials off guard. 

It was a classic watershed moment when 20 of the 33 states across the U.S. that allowed some form of sale and consumption of marijuana had those businesses designated as essential businesses in March during the early days of the coronavirus outbreak. 

Canopy Growth Corp.’s plan to launch cannabis-infused drinks in the U.S. marks the latest attempt by a marijuana company to position itself for a possible weed beverage boom.

The Ontario-based company has licensed rights to its cannabis drinks line in the U.S. to Acreage Holdings Inc., which is expected to soon provide more details. The move comes at an opportune time -- the pot industry is hopeful for U.S. legalization as soon as 2021 and Americans are drinking less alcohol during the coronavirus pandemic.

It took some time, but Canadian cannabis producers appear​ to have finally embraced selling cheaper pot. 

The so-called value segment of the Canadian cannabis market - defined by one analyst as having a retail price below $6 per gram - has exploded in recent months: it accounted for slightly more than 40 per cent of all dried flower sales in July, up from 10 per cent of the market last September, according to industry data provider Headset. 

The popularity of these “value" products has helped companies like Aurora Cannabis Inc. and Canopy Growth Corp. report better-than-expected quarterly sales figures, while also providing consumers with a competitively priced product that could lure people away from the illicit market. 

A study of consumer attitudes released recently found that residents of states with legal cannabis have a positive view of the regulated marketplace. Results of the research, “Consumer perceptions of ‘legal’ and ‘illegal’ cannabis in US states with legal cannabis sales,” were released online last month ahead of the publication of the study in the journal Addictive Behaviors early next year.

There has never been a more crucial time to automate your cannabis operation. With the COVID-19 crisis settling in for the long haul, businesses are starting to think about how to increase efficiency and profit, while operating a facility safely and comfortably for workers and managers.

As the cannabis sector becomes more competitive, the margins get tighter, and the manufacturing and production environment encounter new challenges, businesses must embrace automation to survive.

Need convincing? Here are the top five reasons to automate your cannabis business now.

How Will This Big Issue Affect Pot Stocks

The cannabis start-up is a place where dreams are born. A place where exuberance pulses through the bloodstream, fueling visions of world domination. It’s a place where the new and the old, the novice and the experienced, the tried and the true have all taken their shot. And most of them have failed.

Many others are waiting for the right moment when they come off the sidelines and show the rest how it’s done. Many equate cannabis to a “gold rush” for all these reasons and more. Not the least of which is the notion that this emerging industry is a lot of fun to be a part of. The parties are sensational. What’s not to love?

Let’s talk about pain and cannabis. No, I’m not talking about medical efficacy, although that’s well proven. I’m referring to the great pains that come with regulatory compliance.

There are so many bureaucratic hoops for a business to jump through, it borders on ridiculous. 

It took some time, but Canadian cannabis producers appear​ to have finally embraced selling cheaper pot. 

The so-called value segment of the Canadian cannabis market - defined by one analyst as having a retail price below $6 per gram - has exploded in recent months: it accounted for slightly more than 40 per cent of all dried flower sales in July, up from 10 per cent of the market last September, according to industry data provider Headset. 

The popularity of these “value" products has helped companies like Aurora Cannabis Inc. and Canopy Growth Corp. report better-than-expected quarterly sales figures, while also providing consumers with a competitively priced product that could lure people away from the illicit market.